Advertisement

Molecular and Cellular Biochemistry

, Volume 304, Issue 1–2, pp 13–23 | Cite as

UDN glycoprotein inhibits activator protein-1 and matrix metalloproteinase-9 via blocking of oxygen radicals in HT-29 cells

  • Sei-Jung Lee
  • Kye-Taek Lim
Article

Abstract

The present study was performed to investigate the anti-inflammatory potential of a 116-kDa glycoprotein isolated from Ulmus davidiana Nakai (UDN glycoprotein) in lipopolysaccaride (LPS)-treated cancerous human colon epithelial cells (HT-29 cells). UDN glycoprotein inhibited the production of intracellular superoxide anion (O 2 ·− ), hydrogen peroxides (H2O2), and nitric oxide (NO), whereas normalized the activity of anti-oxidant enzymes [superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GPX)], accompanying the inhibition of manganese-superoxide dismutases (Mn-SOD) activity in LPS-treated HT-29 cells. In addition, UDN glycoprotein blocked the DNA binding activity of activator protein-1 (AP-1) through suppression of c-Jun and c-Fos activities, respectively. We also evaluated the anti-inflammatory potential of UDN glycoprotein based on the activity of the pro-inflammatory signal mediators [inducible nitric oxide synthase (iNOS), cyclooxygenase-2 (COX-2), and matrix metalloproteinases-9 (MMP-9)]. The results showed that UDN glycoprotein (200 μg/ml) has an inhibitory effect on the activation of iNOS, COX-2, and MMP-9 proteins in the LPS-treated HT-29 cells. From these results, we suggest that UDN glycoprotein is one of the potential anti-inflammatory agents that blocks LPS-mediated inflammatory signal pathway in HT-29 cells. Here, we speculate that UDN glycoprotein could be used as an antioxidative agent for inflammatory gastrointestinal cancers.

Keywords

UDN glycoprotein Manganese-superoxide dismutases Activator protein-1 Matrix metalloproteinases-9 HT-29 cells 

Notes

Acknowledgments

This work was supported by the Korea Research Foundation Grant funded by the Korean Government (MOEHRD) (KRF-2005-041-F00082).

References

  1. 1.
    Haller D, Jobin C (2004) Interaction between resident luminal bacteria and the host: can a healthy relationship turn sour? J Pediatr Gastroenterol Nutr 38:123–136PubMedCrossRefGoogle Scholar
  2. 2.
    Bhattacharyya J, Biswas S, Datta AG (2004) Mode of action of endotoxin: role of free radicals and antioxidants. Curr Med Chem 11:359–368PubMedCrossRefGoogle Scholar
  3. 3.
    Kim JS, Narula AS, Jobin C (2005) Salvia miltiorrhiza water-soluble extract, but not its constituent salvianolic acid B, abrogates LPS-induced NF-kappaB signalling in intestinal epithelial cells. Clin Exp Immunol 141:288–297PubMedCrossRefGoogle Scholar
  4. 4.
    Cario E, Rosenberg IM, Brandwein SL, Beck PL, Reinecker HC, Podolsky DK (2000) Lipopolysaccharide activates distinct signaling pathways in intestinal epithelial cell lines expressing Toll-like receptors. J Immunol 164:966–972PubMedGoogle Scholar
  5. 5.
    Gardiner KR, Halliday MI, Barclay GR, Milne L, Brown D, Stephens S, Maxwell RJ, Rowlands BJ (1995) Significance of systemic endotoxaemia in inflammatory bowel disease. Gut 36:897–901PubMedGoogle Scholar
  6. 6.
    Kruidenier L, Verspaget HW (2002) Oxidative stress as a pathogenic factor in inflammatory bowel disease—radicals or ridiculous? Aliment Pharm Ther 16:1997–2015CrossRefGoogle Scholar
  7. 7.
    Kinnula VL, Crapo JD (2004) Superoxide dismutases in malignant cells and human tumors Free Radic Biol Med 36:718–744PubMedCrossRefGoogle Scholar
  8. 8.
    Visner GA, Dougall WC, Wilson JM, Burr IA, Nick HS (1990) Regulation of manganese superoxide dismutase by lipopolysaccharide, interleukin-1, and tumor necrosis factor. Role in the acute inflammatory response J Biol Chem 265:2856–2864PubMedGoogle Scholar
  9. 9.
    Shull S, Heintz NH, Periasamy M, Manohar M, Janssen YM, Marsh JP, Mossman BT (1991) Differential regulation of antioxidant enzymes in response to oxidants J Biol Chem 266:24398–24403PubMedGoogle Scholar
  10. 10.
    Nelson KK, Melendez JA (2004) Mitochondrial redox control of matrix metalloproteinases Free Radic Biol Med 37:768–784PubMedCrossRefGoogle Scholar
  11. 11.
    Kruidenier L, Kuiper I, van Duijn W, Marklund SL, van Hogezand RA, Lamers CB, Verspaget HW (2003) Differential mucosal expression of three superoxide dismutase isoforms in inflammatory bowel disease J Pathol 201:7–16PubMedCrossRefGoogle Scholar
  12. 12.
    Surh YJ, Kundu JK, Na HK, Lee JS (2005) Redox-sensitive transcription factors as prime targets for chemoprevention with anti-inflammatory and antioxidative phytochemicals J Nutr 135:2993S–3001SPubMedGoogle Scholar
  13. 13.
    Eferl R, Wagner EF (2003) AP-1: a double edged sword in tumorigenesis. Nat Rev Cancer 3:859–868PubMedCrossRefGoogle Scholar
  14. 14.
    Sen CK, Packer L (1996) Antioxidant and redox regulation of gene transcription. FASEB J 10:709–720PubMedGoogle Scholar
  15. 15.
    de la Lastra CA, Villegas I (2005) Resveratrol as an anti-inflammatory and anti-aging agent: mechanisms and clinical implications Mol Nutr Food Res 49:405–430CrossRefGoogle Scholar
  16. 16.
    Mook OR, Frederiks WM, Van Noorden CJ (2004) The role of gelatinases in colorectal cancer progression and metastasis Biochim Biophys Acta 1705:69–89PubMedGoogle Scholar
  17. 17.
    Lee SJ, Heo KS, Oh PS, Lim K, Lim KT (2004) Glycoprotein isolated from Ulmus davidiana Nakai inhibits TPA-induced apoptosis through nuclear factor-kappa B in NIH/3T3 cells Toxicol Lett 146:159–174PubMedCrossRefGoogle Scholar
  18. 18.
    Ko JH, Lee SJ, Lim KT (2005) 116 kDa glycoprotein isolated from Ulmus davidiana Nakai (UDN) inhibits glucose/glucose oxidase (G/GO)-induced apoptosis in BNL CL.2 cells J Ethnopharmacol 100:339–346PubMedCrossRefGoogle Scholar
  19. 19.
    Lee SJ, Oh PS, Ko JH, Lim K, Lim KT (2006) Protective effect of glycoprotein isolated from Ulmus davidiana Nakai on carbon tetrachloride-induced mouse liver injury J Pharm Pharmacol 58:143–152PubMedCrossRefGoogle Scholar
  20. 20.
    Suzuki M, Hisamatsu T, Podolsky DK (2003) Gamma interferon augments the intracellular pathway for lipopolysaccharide (LPS) recognition in human intestinal epithelial cells through coordinated up-regulation of LPS uptake and expression of the intracellular Toll-like receptor 4-MD-2 complex Infect Immun 71:3503–3511PubMedCrossRefGoogle Scholar
  21. 21.
    Neville DM, Glossmann H (1974) Molecular weight determination of membrane protein and glycoprotein subunits by discontinuous gel electrophoresis in dodecyl sulfate Methods Enzymol 32:92–102PubMedGoogle Scholar
  22. 22.
    Royall JA, Ischiropoulos H (1993) Evaluation of 2′,7′-dichlorofluorescin and dihydrorhodamine 123 as fluorescent probes for intracellular H2O2 in cultured endothelial cells. Arch Biochem Biophys 302:348–355PubMedCrossRefGoogle Scholar
  23. 23.
    Zhang Z, Leonard SS, Huang C, Vallyathan V, Castranova V, Shi X (2003) Role of reactive oxygen species and MAPKs in vanadate-induced G(2)/M phase arrest. Free Radic Biol Med 34:1333–1342PubMedCrossRefGoogle Scholar
  24. 24.
    Beauchamp C, Fridovich I (1971) Superoxide dismutase: improved assays and an assay applicable to acrylamide gels. Anal Biochem 44: 276–287PubMedCrossRefGoogle Scholar
  25. 25.
    Thomson JF, Nance SL, Tollaksen SL (1978) Spectrophotometric assay of catalase with perborate as substrate. Proc Soc Exp Biol Med 157: 33–35PubMedGoogle Scholar
  26. 26.
    Paglia DE, Valentine WN (1967) Studies on the quantitative and qualitative characterization of erythrocyte glutathine peroxidase. J Lab Clin Med 70: 158–169PubMedGoogle Scholar
  27. 27.
    Lee SJ, Oh PS, Ko JH, Lim K, Lim KT (2004) A 150-kDa glycoprotein isolated from Solanum nigrum L. has cytotoxic and apoptotic effects by inhibiting the effects of protein kinase C alpha, nuclear factor-kappa B and inducible nitric oxide in HCT-116 cells. Cancer Chemother Pharmacol 54: 562–572PubMedCrossRefGoogle Scholar
  28. 28.
    Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the folin phenol reagent. J Biol Chem 193:265–275PubMedGoogle Scholar
  29. 29.
    Lee SJ, Lim KT (2006) Apoptosis induced by glycoprotein (150-kDa) isolated from Solanum nigrum L. is not related to intracellular reactive oxygen species (ROS) in HCT-116 cells. Cancer Chemother Pharmacol 57:507–516PubMedCrossRefGoogle Scholar
  30. 30.
    Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR (1982) Analysis of nitrate, nitrite, and [15N] nitrate in biological fluids. Anal Biochem 126:131–138PubMedCrossRefGoogle Scholar
  31. 31.
    Fridovich I (1983) Superoxide radical: an endogenous toxicant. Annu Rev Pharmacol Toxicol 23:239–257PubMedCrossRefGoogle Scholar
  32. 32.
    Lakari E, Paakko P, Kinnula VL (1998) Manganese superoxide dismutase, but not CuZn superoxide dismutase, is highly expressed in the granulomas of pulmonary sarcoidosis and extrinsic allergic alveolitis. Am J Respir Crit Care Med 158:589–596PubMedGoogle Scholar
  33. 33.
    Clerch LB, Massaro D (1993) Tolerance of rats to hyperoxia. Lung antioxidant enzyme gene expression J Clin Invest 91:499–508PubMedCrossRefGoogle Scholar
  34. 34.
    Surh YJ, Chun KS, Cha HH, Han SS, Keum YS, Park KK, Lee SS (2001) Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-kappa B activation. Mutat Res 480–481:243–268PubMedGoogle Scholar
  35. 35.
    Crowell JA, Steele VE, Sigman CC, Fay JR (2003) Is inducible nitric oxide synthase a target for chemoprevention? Mol Cancer Ther 2:815–823PubMedGoogle Scholar
  36. 36.
    Hill KA, Wang KL, Stryker SJ, Gupta R, Weinrach DM, Rao MS (2004) Comparative analysis of cell adhesion molecules, cell cycle regulatory proteins, mismatch repair genes, cyclooxygenase-2, and DPC4 in carcinomas arising in inflammatory bowel disease and sporadic colon cancer. Oncol Rep 11:951–956PubMedGoogle Scholar
  37. 37.
    Bachschmid M, Schildknecht S, Ullrich V (2005) Redox regulation of vascular prostanoid synthesis by the nitric oxide-superoxide system. Biochem Biophys Res Commun 338:536–542PubMedCrossRefGoogle Scholar
  38. 38.
    Hinz B, Brune K (2002) Cyclooxygenase-2–10 years later. J Pharmacol Exp Ther 300:367–375PubMedCrossRefGoogle Scholar
  39. 39.
    Kouzarides T, Ziff E (1988) The role of the leucine zipper in the fos-jun interaction. Nature 336:646–651PubMedCrossRefGoogle Scholar
  40. 40.
    Naito Y, Yoshikawa T (2005) Role of matrix metalloproteinases in inflammatory bowel disease. Mol Aspects Med 26:379–390PubMedCrossRefGoogle Scholar
  41. 41.
    Kim JH, Lee KW, Lee MW, Lee HJ, Kim SH, Surh YJ (2006) Hirsutenone inhibits phorbol ester-induced upregulation of COX-2 and MMP-9 in cultured human mammary epithelial cells: NF-kappaB as a potential molecular target. FEBS Lett 580:385–392PubMedCrossRefGoogle Scholar
  42. 42.
    Warner RL, Bhagavathula N, Nerusu KC, Lateef H, Younkin E, Johnson KJ, Varani J (2004) Matrix metalloproteinases in acute inflammation: induction of MMP-3 and MMP-9 in fibroblasts and epithelial cells following exposure to pro-inflammatory mediators in vitro. Exp Mol Pathol 76:189–195PubMedCrossRefGoogle Scholar
  43. 43.
    Grau R, Punzon C, Fresno M, Iniguez MA (2006) Peroxisome-proliferator-activated receptor alpha agonists inhibit cyclo-oxygenase 2 and vascular endothelial growth factor transcriptional activation in human colorectal carcinoma cells via inhibition of activator protein-1. Biochem J 395:81–88PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2007

Authors and Affiliations

  1. 1.Molecular Biochemistry Laboratory, Biotechnology Research Institute and Center for the Control of Animal Hazards Using Biotechnology (BK 21)Chonnam National UniversityKwang-juSouth Korea
  2. 2.Molecular Biochemistry Laboratory, Institute of BiotechnologyChonnam National UniversityKwang-juSouth Korea

Personalised recommendations